CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
Patent Owner
Stats
- 60 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Feb 20, 2018 most recent publication
Details
- 60 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 507 Total Citation Count
- May 22, 1991 Earliest Filing
- 57 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0317,674 CONJUGATE COMPRISING ERYTHROPOIETIN AND A BRANCHED POLYMER STRUCTUREJan 08, 15Nov 03, 16[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9896482 Beta hairpin peptides having antiviral properties against Dengue virusFeb 26, 15Feb 20, 18[A61K, C07K]
9717776 Vesicles comprising epidermal growth factor and compositions thereofAug 02, 13Aug 01, 17[A61K, A61Q, A61L]
9603900 Use of PACAP for the treatment of viral infections in aquatic organismsAug 28, 15Mar 28, 17[A61K]
9518085 Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseasesJun 29, 12Dec 13, 16[A61K, C07K]
9505830 Recombinant antibodies to the vascular endothelial growth factor (VEGF) which are obtained by means of mutagenesis of variable regionsDec 26, 11Nov 29, 16[A61K, C07K]
9364524 Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogenMar 19, 15Jun 14, 16[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0011,216 ENGINEERED PERTACTIN VARIANTS FOR VACCINE USEAbandonedAug 14, 13Jan 09, 14[G01N, C07K]
2012/0308,615 FORMULATION OF HEPATITIS B VIRUS ANTIGENS FOR CELLULAR STIMULATION FOLLOWED BY THERAPEUTIC IMMUNIZATIONAbandonedSep 28, 10Dec 06, 12[A61K, C12N, A61P]
8110182 Treatment of multiple sclerosis by administration of interferon alpha and C-phycocyaninExpiredOct 30, 06Feb 07, 12[A61K, C07K]
7919463 Growth-stimulating polypeptides for use in fish and crustaceansExpiredJun 23, 06Apr 05, 11[A61K, C07K]
2010/0172,931 Pharmaceutical Composition Containing the NMB1796 ProteinAbandonedJun 16, 08Jul 08, 10[A61K, C12Q, A61P, C07K]
2010/0151,566 RECOMBINANT ANTIBODIES AGAINST THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)AbandonedOct 30, 07Jun 17, 10[C12N, C07K]
2010/0129,387 PHARMACEUTICAL COMPOSITION CONTAINING THE NMB0606 PROTEINAbandonedMar 29, 07May 27, 10[A61K, G01N, A61P, C07K]
2010/0093,616 Combination of EGF/GHRP-6 for Neurogeneration of Central Nervous System Following Autoimmune DamageAbandonedFeb 24, 06Apr 15, 10[A61K]
7691971 Protein NMB1125 and use thereof in pharmaceutical formulationsExpiredDec 02, 04Apr 06, 10[C07K]
2009/0324,644 CHIMERIC VACCINE ANTIGENS AGAINST THE AVIAN INFLUENZA VIRUSAbandonedFeb 28, 07Dec 31, 09[A61K]
2009/0312,190 Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other FlavivirusesAbandonedNov 21, 06Dec 17, 09[A61K, C07H, C12N, C40B, C07K]
2009/0297,547 PHARMACEUTICAL COMPOSITION CONTAINING THE NMB0938 PROTEINAbandonedMar 29, 07Dec 03, 09[A61K, C12Q, G01N, C07K]
2009/0221,512 PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6 TO PREVENT AND ELIMINATE FIBROSIS AND OTHER PATHOLOGICAL DEPOSITS IN TISSUESAbandonedFeb 23, 07Sep 03, 09[A61K]
2009/0208,521 PHARMACEUTICAL COMPOSITIONS CONTAINING PROTEIN NMA0939AbandonedDec 28, 06Aug 20, 09[A61K, A61P]
7566457 Chimeric proteins that induce effects directed against virusesExpiredFeb 13, 07Jul 28, 09[A61K, C12Q, C07K]
2009/0074,850 USE OF A TOPICAL COMPOSITION CONTAINING EPIDERMAL GROWTH FACTOR (EGF) FOR DIABETIC FOOT AMPUTATION PREVENTIONAbandonedDec 28, 06Mar 19, 09[A61K, A61P]
2008/0280,354 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virusAbandonedJul 14, 06Nov 13, 08[C07H, C12N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.